Dey settles AWP litigation
Executive Summary
Merck KGaA subsidiary Dey reaches Medicaid reimbursement settlements with Nevada and Hawaii (March 29 and March 21, respectively) regarding alleged misrepresentations of average wholesale price. Dey will pay $670,000 to Nevada and $946,992 to Hawaii. In 2004, Dey paid $18.5 million to settle a Medicare fraud suit brought by the attorney general of Texas, and currently has suits in several states (1"The Pink Sheet" Feb. 12, 2007, p. 23)...
You may also be interested in...
Sanofi Is Fifth Company To Sign AWP Settlement With DoJ, Pays $190 Mil.
While dozens of pharmaceutical companies are entangled in fraudulent pricing lawsuits, only five have inked a deal with the Department of Justice
AWP Litigation Increases As Justice Dept. Sues Roxane For Price Inflation
Another lawsuit has been added to the tangle of litigation over average wholesale drug pricing
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.